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the rheumatology rotation at our institution. It incorporates 
many of the suggestions in the editorial by Stross: a mul- 
tidisciplinary approach, clinical rounds, formal rheumatol- 
ogy lectures, interaction with personnel from related subspe- 
cialties, and allied health workshops on selected topics. The 
arrangement of this schedule is flexible, and the various 
components can be adjusted according to the resources of 
the institution and needs of the trainees. Additionally, by 
changing the blocks, emphasis can be easily shifted to 
inpatient or outpatient training. 
Based on our experience of rheumatology training 
for nonrheumatologists, we would like to propose that 
residents in family medicine who have successfully com- 
pleted such training be eligible for rheumatology fellowship. 
This would heighten interest in clinical rheumatology among 
practicing family physicians, the primary health care provid- 
ers for the majority of patients with rheumatic disorders, and 
would generate a pool of well-trained and interested family 
practice residents to pursue careers in rheumatology. Family 
practice residents are already eligible for fellowships in 
various subspecialties such as gerontology, preventive med- 
icine, and sports medicine. 
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Reply 
To the Editor: 
1 concur with Dr. Harrington that community rheu- 
matologists can play an important role in attracting trainees 
into the field of rheumatology, but the initial problem is one 
of exposure. A recent survey of medical school graduates, 
carried out by the Association of American Medical Col- 
leges, documented that more than 80% of the graduates 
selecting careers in internal medicine made that decision 
during the last 2 years of medical school. The opportunities 
for interaction with community rheumatologists are limited 
during that critical period, and the role of clinical rheuma- 
tologists in academic centers becomes increasingly impor- 
tant. I t  would be interesting to assess where rheumatology 
trainees had their house officer training and when they made 
the decision to enter rheumatology, as additional data points 
for program planning purposes. 
The distribution of funds from the NIH will always 
be a source of concern, since basic scientists, clinical 
researchers, and politicians all have their own agendas. The 
fact that the NIH has taken the lead in developing the 
“Academic Award” concept and the basic researchers who 
populate most NIH councils have approved these awards 
speaks to their perceived value. 
The educational program developed by Dr. Agarwal 
and colleagues is an excellent example of how community 
rheumatologists can incorporate clinical rheumatology into 
family medicine training programs and produce significant 
improvements in knowledge, skills, and attitudes. Agarwal 
et al now propose that family medicine trainees be eligible 
for rheumatology fellowships. That career path has been 
followed by a few trainees to date, and while subspecialty 
certification is not possible, this has not been problematic. 
This approach could expand the potential pool of fellows, 
but raises several issues: Is the 3 years of internal medicine 
house officer training prior to fellowship necessary? Should 
subspecialty certification requirements be changed? Is cer- 
tification necessary and valuable? These issues have been 
addressed in the field of gerontology, where family medicine 
trainees can participate in fellowship programs, and they 
should be addressed by the ACR. 
The ACR’s efforts to address manpower issues are 
ongoing, and it is important that a variety of alternatives be 
considered, irrespective of their source. The ACR must 
work in conjunction with the NIH, the Agency for Health 
Care Policy and Research, and other federal agencies that 
may be in a position to change resource allocation and 
facilitate funding of educational initiatives. There will obvi- 
ously be a variety of approaches to address the manpower 
issues, and the ACR Manpower and Training Committee is 
an appropriate forum for these discussions. 
Jeoffrey K. Stross, MD 
University .J‘Michigan Medical Center 
Ann Arbor. MI 
Of names and abbreviations 
To the Editor: 
The use of abbreviations has become a time-honored 
custom in the writing and practice of medicine. Certainly, 
who would not recognize, at least in rheumatology circles, 
that “RA” and “SLE” refer to “rheumatoid arthritis” and 
“systemic lupus erythematosus,” respectively. The wide- 
spread use of abbreviations in medicine indeed seems prac- 
tical in our communications with colleagues. One could 
argue, however, that for some people, the English designa- 
tion “SLE” may mean something entirely different, such as 
St. Louis encephalitis. In fact, not too long ago, a Houston 
newspaper printed in large letters on its front page that 
Texas was again facing another epidemic of SLE. 
I have recently noticed two articles published in 
Arthritis and Rheumatism in which the use of abbreviations 
could similarly confuse the reader-rheumatologist. The arti- 
cle by Wigley et al (1) uses the abbreviation “ACA” to refer 
to the presence of anticentromere antibody. Yet, for most 
rheumatologists, “ACA” would bring to mind “anticardio- 
lipin antibody.” In another article, Khraishi et al (2) use the 
